Medicare Enrolled

Dr. Donald Ingle, M.D.

Family Medicine · Arlington, TX
Low-engagement
1926 SW GREEN OAKS BLVD, Arlington, TX 76017
8174725522
In practice since 2006 (20 years)
NPI: 1972563492 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ingle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ingle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ingle

Dr. Donald Ingle is a family medicine specialist in Arlington, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Ingle received a total of $3,970 from 41 pharmaceutical and/or device companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ingle is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $3,970 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,970
Total received (2018-2024)
Avg $567/year across 7 years
Top 16% in TX for family medicine
41
Companies
245
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,970 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,034
2023
$936
2022
$307
2021
$107
2020
$195
2019
$467
2018
$925

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$513
Lilly USA, LLC
$428
GlaxoSmithKline, LLC.
$351
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
PFIZER INC.
$181
Merz North America, Inc.
$165
Allergan Inc.
$165
Bayer Healthcare Pharmaceuticals Inc.
$149
Astellas Pharma US Inc
$142
Janssen Pharmaceuticals, Inc
$141
AstraZeneca Pharmaceuticals LP
$122
Tris Pharma Inc
$122
Novo Nordisk Inc
$117
Abbott Laboratories
$109
Amgen Inc.
$95
Teva Pharmaceuticals USA, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$76
Merck Sharp & Dohme Corporation
$71
Amarin Pharma Inc.
$59
SANOFI-AVENTIS U.S. LLC
$59
Allergan, Inc.
$55
AbbVie Inc.
$54
Dexcom, Inc.
$50
Exact Sciences Corporation
$41
E.R. Squibb & Sons, L.L.C.
$39
Novartis Pharmaceuticals Corporation
$35
ARBOR PHARMACEUTICALS, INC.
$29
Synergy Pharmaceuticals Inc
$28
Insulet Corporation
$25
Ironwood Pharmaceuticals, Inc
$23
Biohaven Pharmaceutical Holding Company Ltd.
$21
Medtronic, Inc.
$19
Supernus Pharmaceuticals, Inc.
$17
Merck Sharp & Dohme LLC
$17
IBSA Pharma Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
SANOFI PASTEUR INC.
$14
Kowa Pharmaceuticals America, Inc.
$13
Antares Pharma, Inc.
$13
Shire North American Group Inc
$11
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 32.6% of total payments
Associated products mentioned in payments ›
AIMOVIG · AIRSUPRA · AJOVY · ANORO · Aimovig · BEXSERO · BREZTRI · BYSTOLIC · CHANTIX · Cologuard Collection Kit · DRG IPGs · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · Edarbyclor · FARXIGA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE · FreeStyle Libre · GARDASIL · Horizant · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · Linzess · Livalo · METHYLPHENIDATE 72 · MOUNJARO · MYDAYIS · MYRBETRIQ · NUCALA · NURTEC ODT · Omnipod · Otezla · Ozempic · Prolia · QULIPTA · REXULTI · SHINGRIX · SOLIQUA 100/33 · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TZIELD · Tirosint · Tresiba · Trulance · UBRELVY · VENASEAL · VIBERZI · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XEOMIN · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Arlington?
Compare family medicine physicians in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,308
Per 100K population
61.2
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ingle is a family medicine specialist, with low-engagement industry engagement in the top 16% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ingle receive payments from pharmaceutical companies?
Yes. Dr. Ingle received a total of $3,970 from 41 companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ingle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →